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ABSTRACT
Background: Gastric cancer (GC) is the fifth common malignant disease and the third leading 
cause of cancer-related mortality in the world. Ardabil, a Northwestern province of Iran, includes 
the highest rate of GC within the country. Helicobacter pylori (H. pylori) vacA gene plays a 
major role in generating and maintaining the gastric inflammatory response, which alters the 
enteric nervous system in various combinations and may contribute to the development of GC. 
The aim of the current study was to investigate the relationship of the vacA c-region genotypes 
of H. pylori with GC among Ardabil population.
Methods: A total of 197 from 259 patients with non-atrophic gastritis (NAG) and GC, who 
were H. pylori positive, were selected and genotyped.
Results: The frequency of vacA c1 was 53.7% and c2 42.3%. There was a significant difference 
between the frequencies of vacA c1 in isolates from GC than those from NAG (p<0.05). Though 
the GC was considered as a dependent factor by the multiple logistic regression analysis, the 
vacA c1 genotype was significantly associated with age- and sex-adjusted risk for GC (p=0.003, 
odds ratio [OR] = 5.48; 95% confidence interval [CI] =1.80–16.63).
Conclusion: It was proposed that the H. pylori vacA c1 genotype could be considered as an 
important determinant for prediction of risk of GC in Ardabil. It is suggested that interaction 
between H. pylori vacA c-region genotypes and gastric nervous system may contribute to the 
development of GC.
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INTRODUCTION
Gastric cancer (GC) is the fifth most common cancer 
worldwide and the third leading cause of cancer leading 
to death 1. GC incidence rate is high in Asia (Almost two-
thirds) 2. Iran has the fourth -ranking of GC in Asia, after 
China, Japan and Korea respectively3-7. The incidence of 
GC in the Northern districts of Iran, particularly Ardabil 
Province located in northwestern Iran, where the incidence 
of GC is high, has been reported to be considerably high 
(ASR of 51.8/100,000 men and 24.9/100,000 women) 8,9. 
There is a close relationship between increased risk of GC 
in high risk regions and Helicobacter pylori (H. pylori) 
infection 10. The 63% of all GC are related to H. pylori 
infection11; however, less than 3% of infected individuals 
develop GC11, 12. The prevalence of H. pylori infection is 
69% in Iran; and the highest frequency (89%) is reported 
in Ardabil13. Strains isolated from Iranian populations, 
including those with Ardabil signature, are likely to be 
of European ancestry14.
One of the pathogenic mechanisms of H. pylori changes 
in the various components of the gastric nervous system, 
including structural anomalies, sensitivity and motor 
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function impairment and changes in neurotransmitter is 
released. Interaction of H. pylori with gastric nervous 
system results in neurons’ dysfunction that may play a 
potential role in development of GC 15.
H. pylori virulence factors could determine the outcome 
of infection when combined with both environmental and 
host factors 16. One independent H. pylori locus that is 
correlated with increased risk of disease is vacuolating 
cytotoxin A (vacA). Suppressing T cell activity, VacA 
causes a change in function of the immune response 
and plays an important role in generating and sustaining 
the inflammatory response plays stomach 17. Mucosal 
inflammatory response associated to H. pylori infection 
leads to afferent nerve remodeling and may contribute 
to the development and processing of various types of 
diseases including GC.
Genetic studies have shown that the presence of vacA 
is associated with the development of peptic ulcer, severe 
gastritis, both premalignant and malignant lesions 18 and 
comprises several polymorphic regions: the signal (s), 
encoding a part of the N terminus of the mature protein; 
middle (m), encoding a part of the 55-kDa C-terminal 
subunit; intermediate (i), located between s and m regions 
possessing a functional role in vacuole-creating activities, 
and deletion (d) region. Recently, a 15 bp deletion located 
at the 3ʹ-end region of H. pylori vacA has been identified 
and termed the c-region, as c1 (with deletion) and c2 (no 
deletion), which associated with different gastroduodenal 
diseases 19. We aimed to determine the impact of H. 
pylori vacA c-region genotypes, age and gender on the 
development of GC among Ardabil population.
MATERIALS AND METHODS
A total of 259 patients affected with non-atrophic 
gastritis (NAG) and GC; who referred to the Endoscopy 
unit at the Imam Khomeini Hospital in Ardabil participated 
in the study. Gastric biopsy specimens were taken from 
the antrum and/or the corpus, and classified by endoscopic 
and histopathological examinations.
DNA extraction and diagnosis of H. pylori 
infection and genotyping of H. pylori
H. pylori infection was diagnosed by rapid urease test 
and PCR amplification of H. pylori 16S rDNA. DNA was 
extracted from the biopsy specimens with the Genomic 
DNA Purification kit (DNGTM-Plus, CinnaGen Co., Iran) 
according to the manufacturer’s protocol and stored at 
-20°C. Polymerase chain reaction (PCR) was performed 
in a volume of 30 μL reaction volume containing 50 ng of 
genomic DNA, 3 μL of 10X PCR buffer (CinnaGen, Iran), 
1 mM MgCl2, 200 μM of each dNTP (CinnaGen Co., 
Iran), 0.5 μM of each specific primer and 2 U of Taq DNA 
polymerase (CinnaGen Co., Iran). The PCR conditions 
were 96°C for 3 min and then 35 cycles of 96°C for 40 
seconds, optimized annealing temperature for each allele 
(Table 1) for 40 seconds, 72°C for 40 seconds, and a 
final incubation at 72°C for 7 min. PCR products were 
electrophoresed and visualized by a UV trans illuminator 
(Figure 1). As controls, amplified fragments of each gene/
allele from ten isolates were purified and sequenced 
with both forward and reverse primers using a BigDye 
technology on an ABI3700XL DNA sequencer (Applied 
Biosystems). The BLAST program (http://www.ncbi.nlm. 
nih.gov) was used to match the nucleotide sequences 
with the published sequences in GenBank.
Data analysis
Data collected and analyzed using binary logistic 
regression model and the Chi-square (χ2) or Fisher’s exact 
tests in SPSS software (version 19); P value of < 0.05 
indicated statistically significant level. Odds ratios (ORs) 
and the corresponding 95% confidence intervals (CIs) 
were also computed. For determine the effect of each 
allele in GC, using simple logistic regression analysis by 
the Enter method. The Forward Stepwise LR (Likelihood 
Ratio) multiple logistic regression analysis was used for 
each allele, with adjustment for the potential confounders, 
including a threshold age of ≥55 years and sex.




16 S rDNA HP1
HP2
GCA ATC AGC GTC AGT AAT GTT C







ATC ATY SGT TAT GRH AAT GTT TCT
TTA TGC TCT AAA CTG GCT A
ATT ATA ATT TAG TAG GAG TGC AAG G





Table 1. Oligonucleotide Primers Used for PCR
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Histopathologic Examination and Classification 
of Subjects
Gastric biopsy specimens were taken from pyloric 
gland area (the antrum) and fundic gland area (the corpus). 
One biopsy from the antrum and/or fundus was fixed 
in 10% formalin and embedded in paraffin. The tissue 
sections for histopathologic examinations were provided, 
and then the histo-morphologic architecture of the tumors 
was expressed according to Lauren’s classification as 
intestinal or diffuse carcinomas. Biopsies were stained 
with hematoxylin–eosin, Alcian blue-periodic acid 
Shiff (pH 2.5) and Giemsa for light microscopy, and 
histopathological evaluations were also applied according 
to the updated Sydney classification system20.
RESULTS
Classification of patients and presence of H. 
pylori in gastric biopsy specimens
A total of 259 patients from rural and urban areas of 
Ardabil with non-atrophic gastritis (186) and GC (73) 
participated in the current study. Histopathological 
evaluations were performed for samples. Patients were 
classified into 2 groups; females: 45.9% and males: 54.1%. 
Patients were also classified into 2 age groups; age <55 
(54.4%) and age ≥55 (45.9%). The age information was 
not available for one patient. Of 73 patients with GC, 
86.3% had age ≥55 and 72.6% were male. GC was more 
common among patients with age ≥55 and male group. In 
NAG group, 29.0% of patients were age ≥55, and 46.8% 
were male. Characteristics of patients according to age and 
sex were shown in Table 2. The current study, statistical 
analysis showed that both the age ≥55 and male sex were 
significantly associated with GC [OR (95% CI) = 3.01 
(1.67-5.43) and 17.11 (7.94-36.83), respectively; P = 0.00] 
(Table 3). 197 (76.1%) patients were infected by H. pylori. 
Electrophoresis of the PCR products of 16S rDNA for 
46.19% (91/197) of patients revealed bands with the size 
of 519 bp which confirmed the presence of H. pylori.
The prevalence of H. pylori vacA c genotypes 
and its correlation with the risk of GC
The vacA c-region genotypes could be determined in 
Figure 1. PCR products of c region of the vacA gene.
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82 H. pylori-positive patients. They were not detected 
in nine specimens, so were excluded from the analysis. 
Generally, a total of 82 H. pylori-positive patients, 43 
(52.4%) with GC and 39 (47.6%) with NAG, were 
enrolled in the final analysis. The size of the PCR 
products of the vacA c1 and vacA c2 genotypes was 
600-700 bp. The amplified products of the vacA c1 and 
vacA c2 genotypes showed more than 96% similarity 
with those in GenBank. Total prevalence of vacA c1 
was 57.3% and c2 42.7%. As shown in Table 4, the 
frequency of the vacA c1 genotype in patients with GC 
was 74.4, and in NAG group was 38.5%. There was a 
significant difference between the frequencies of vacA 
c1 in isolates from GC than those from NAG (p<0.05). 
The results of simple logistic regression analysis showed 
that this genotype was significantly associated with the 
risk of GC; the OR (95% CI) was 4.65 (1.81-11.92; P 
= 0.02). Though the GC was considered as a dependent 
factor by the multiple logistic regression analysis, the 
vacA c1 genotype was significantly associated with the 
age- and sex-adjusted risk for GC (p= 0.003, OR = 5.48; 
95% CI =1.80–16.63).
DISCUSSION
Gastric cancer is very common in Ardabil, a 
Northwestern province of Iran with the highest GC 
incidence rate in the country. There is a close relationship 
between H. pylori-specific factors and GC. Ardabil is a 
province with a high prevalence of H. pylori infection 
(89%). Strains with the particular vacA genotypes have 
been found to be benefit biomarkers for GC. A recent 
follow-up study performed on 321 patients from a 
high-risk area of GC in Spain has shown that infection 
with cagA+/vacA s1/m1 strains was associated with the 
progression of gastric precancerous lesions (OR = 4.80) 
21. The results of a study from Northeastern of Brazil 
where there is a high prevalence of gastric cancer has 
shown that infection with the most virulent H. pylori 
strains, carrying the cagA gene and s1m1 vacA alleles, 
predominates and is correlated with more severe H. 
pylori-associated diseases; and infection with cagA+ 
strains was significantly associated with gastric cancer 
(p = 0.016, OR = 10.36, 95% CI = 1.35-217.31) 22. A 
meta-analysis study on 17374 patients demonstrated that 
individuals carrying strains of H. pylori vacA s1 (vs. s2), 
m1 (vs. m2), s1m1 (vs. s1m2), and s1m1 (vs. s2m2) are 
at an increased risk of developing GC [OR of 5.32 (95% 
CI 2.76-10.26), 2.50 (95% CI 1.67-3.750), 2.58 (95% CI 
1.24-5.38), and 4.36 (95% CI 2.08-9.10), respectively]23.
Recently, two disease-related regions: intermediate (i) 
region (located between sand m regions) and deletion (d) 
Characteristics
Types of gastroduodenal diseases
Non-atrophic gastritis Gastric cancer Total
Patients NO. (%) 186/259 (71.8) 73/259 (28.2) 259/259 (100.0)
Sex groups NO. (%)
Male 87/186 (46.8) 53/73 (72.6) 140/259 (54.1)
Female 99/186 (53.2) 20/73 (27.4) 119/259 (45.9)
Age groups NO. (%)
≥55 54/186 (29.0) 63/73 (86.3) 117/259 (45.2)
<55 132/186 (71.0) 9/73 (12.3) 141/259 (54.4)








P value OR 95% CI
c- region
c1 15/39 (38.5)a 32/43 (74.4) 47/82 (57.3) 0.02 4.65 1.81-11.92
c2 24/39 (61.5) 11/43 (25.6) 35/82 (42.7) 1(ref) 1(ref) 1(ref)
Table 4. Associations between the risk of GC and vacA c-region genotypes
Abbreviations: NAG, non-atrophic gastritis; GC, Gastric cancer; OR, odds ratio; CI, confidence interval.
aBoldface data indicate statistically significant results
Characteristic/
confounder Simple logistic regression
P value OR 95% CI
Gastric cancer
Sex
Male 0.00a 3.01 1.67-5.43
Female 1 (ref) 1 (ref) 1 (ref)
Age, y
≥55 0.00 17.11 7.94-36.83
<55 1 (ref) 1 (ref) 1 (ref)
Table 3. Associations between the risk of gastric cancer and age, 
and gender
Abbreviations: OR, odds ratio; CI, confidence interval.
aBoldface data indicate statistically significant results
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region (located between the i and m regions) have been 
identified as new factors determining of GC risk 24,25. 
The results of a recent meta-analysis study showed that 
the vacA i1 allele of H. pylori is associated with an 
increased risk of GC in the middle Asian (p < 0.001, OR 
= 10.89; 95% CI= 4.11–20.88)26. The results of a study by 
Ferreira et al. 27 on 192 H. pylori-infected patients with 
gastric carcinoma (56), with chronic superficial gastritis 
(114), and with chronic atrophic gastritis (22) from the 
North of Portugal showed that the vacA i1 genotype 
was significantly associated with gastric atrophy and for 
gastric carcinoma, with OR= 8.0; 95% CI=2.3–27.0 and 
OR= 22.0; 95% CI=7.9–63.0, respectively.
Latifi-Navid et al. (2013) have reported that the vacA 
d1/-i1 alleles from strains with European ancestry could 
probably be considered as determinant biomarkers in 
the high incidence areas of GC in Iran (Ardabil and 
Mazanderan) 28. The results of two recent studies from 
East Azerbaijan region in Northwestern Iran, where the 
incidence of GC is high, demonstrated that there are 
high association of the vacA i1 (OR = 13.14) 29 and vacA 
d1genotypes (OR = 8.04) 30 with GC. On the contrary, 
in a study, Ogiwara et al. showed that in East Asia and 
Southeast Asia countries where GC incidence is high, 
there was no correlation between the vacA –s, -m1, 
-i1, and -d1 genotypes and GC. In Western countries, 
strains with vacA s1, m1, i1, or d1 genotypes had a 
significant relationship with risk of GC 25. We have 
recently identified a novel polymorphic site in the 3ʹ- 
end region of H. pylori vacA, denoted by c1/-c2 (c1: with 
deletion of 15 bp). Despite its biological role is not yet 
known, the vacA c1 type has been proposed as a new 
determinant of GC risk. We have previously examined 
217 isolates recovered from 114 patients with NAG, 57 
patients with PUD, and 46 patients with GC, and have 
shown that the vacA m1, i1, d1, c1, and cagA genotypes 
were significantly associated with the risk of GC (OR was 
4.29, 6.11, 3.18, 15.13, and 2.59, respectively), and vacA 
i1 and cagA genotypes with the risk of PUD (OR was 
2.80 and 2.62, respectively). Finally, logistic regression 
analysis showed that the vacA c1 genotype was a strong 
correlation in male GC patients ≥55 than in male NAG 
patients ≥55 the OR was 36.66 (P= 0.004) 19.
In the present study, statistical analysis showed that 
the frequency of the vacA c1 genotype in patients with 
GC was significantly higher than in NAG patients; simple 
logistic regression analysis confirmed the relationship 
between vacA c1 genotype with GC in Ardabil; the OR 
(95% CI) was 4.65 (1.81-11.92; P = 0.02). Finally, after 
controlling for age and sex variables, the vacA c1 genotype 
remained in the final model when the GC was considered 
as a dependent factor by the multiple logistic regression 
analysis. In fact, the results of multiple logistic regression 
confirmed the high correlation of the vacA c1 genotype 
with the risk of GC (p = 0.003, OR = 5.48; 95% CI = 
1.80–16.63). However, it is still not clear biological role 
and its impact on the enteric nervous system. Although 
all of these studies have shown the relationship between 
vacA genotypes of H. pylori to gastric cancer; however, 
none of these genotypes associated with abnormal nerve 
cells of the stomach is not yet known.
CONCLUSION
Results of the present study revealed that the vacA c1 
genotype was strongly associated with the incidence of 
GC in high-risk areas, particularly Ardabil. However, the 
role of the interaction between H. pylori vacA c-region 
genotypes and gastric nervous system is unknown. It is 
suggested that neural activity impaired by this genotype 
may have a potential role in the development of GC, but 
this hypothesis requires further investigation. It seems 
that the unfolding relationship between neurological 
changes caused by inflammation induced by H. pylori 
vacA genotypes could help to identify new therapeutic 
approaches for GC.
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